BBIO - BridgeBio Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BBIO is currently covered by 13 analysts with an average price target of $55.72. This is a potential upside of $19.83 (55.25%) from yesterday's end of day stock price of $35.89.

BridgeBio Pharma's activity chart (see below) currently has 101 price targets and 121 ratings on display. The stock rating distribution of BBIO is 98.25% BUY and 1.75% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50.34% with an average time for these price targets to be met of 199.27 days.

Highest price target for BBIO is $95, Lowest price target is $45, average price target is $51.69.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 15-Apr-2025. First documented stock forecast 22-Jul-2019.

Currently out of the existing stock ratings of BBIO, 56 are a BUY (98.25%), 1 are a HOLD (1.75%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$53

$16.69 (45.97%)

$49

13 days ago
(15-Apr-2025)

5/24 (20.83%)

$18.76 (54.79%)

280

Buy

$50

$13.69 (37.70%)

$43

1 months 4 days ago
(24-Mar-2025)

10/14 (71.43%)

$12.78 (34.34%)

136

Buy

$52

$15.69 (43.21%)

$48

2 months 7 days ago
(21-Feb-2025)

3/7 (42.86%)

$15.19 (41.27%)

220

Buy

$95

$58.69 (161.64%)

$70

2 months 7 days ago
(21-Feb-2025)

1/9 (11.11%)

$58.19 (158.08%)

244

Buy

$49

$12.69 (34.95%)

$45

2 months 7 days ago
(21-Feb-2025)

1/4 (25%)

$12.19 (33.12%)

50

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BBIO (BridgeBio Pharma) average time for price targets to be met?

On average it took 199.27 days on average for the stock forecasts to be realized with a an average price target met ratio 50.34

Which analyst has the current highest performing score on BBIO (BridgeBio Pharma) with a proven track record?

TYLER VAN BUREN

Which analyst has the most public recommendations on BBIO (BridgeBio Pharma)?

Tyler Van Buren works at TD COWEN and has 5 price targets and 3 ratings on BBIO

Which analyst is the currently most bullish on BBIO (BridgeBio Pharma)?

Josh Schimmer with highest potential upside - $58.69

Which analyst is the currently most reserved on BBIO (BridgeBio Pharma)?

Eun Yang with lowest potential downside - -$12.31

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?